(Q22252236)

8 February 2023

Z. Ren

2

Z

Ren

1 reference

8 February 2023

J. Turton

3

J

Turton

1 reference

8 February 2023

G. Pang

4

G

Pang

1 reference

8 February 2023

A. Wettstein

5

A

Wettstein

1 reference

Digestive and Liver Disease

8 February 2023

language of work or name

English

0 references

publication date

May 2007

0 references

published in

0 references

volume

39

0 references

issue

5

0 references

page(s)

445-451

0 references

cites work

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Defective acute inflammation in Crohn's disease: a clinical investigation

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Shift of the gastric T-cell response in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Sequence and characteristics of IS900, an insertion element identified in a human Crohn's disease isolate of Mycobacterium paratuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Images of interest. Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp. paratuberculosis infected Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

The Mycobacteria Story in Crohn's Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

Classification of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

A multiplex polymerase chain reaction assay for the detection of Mycobacterium paratuberculosis DNA in Crohn's disease tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.DLD.2006.12.006

7 January 2021

10.1016/J.DLD.2006.12.006

Identifiers

DOI

0 references

Fatcat ID

release_w66fesexrngaticar3q624q4xy

0 references